Together, pneumonia and influenza rank as the eighth leading cause of death in the United States. 1 While a pathogen is not identified even after extensive diagnostic evaluation in the majority of cases, influenza virus is known to be an important contributor to pneumonia. 2, 3 Factors such as an aging population, changes in population immunity (such as through vaccination and immunosuppressive comorbidities), and persisting socioeconomic disparities might be contributing to a shift in the national burden of pneumonia. 4, 5 While pneumonia disproportionately affects older adults, the mortality rate from pneumonia among older adults is declining. [6] [7] [8] [9] Among children, the very young face the greatest burden of pneumonia, though the introduction of the pneumococcal vaccine (eg, the 7-valent pneumococcal conjugate vaccine [PCV7] in 2000) has had an impact. [10] [11] [12] People who are immunocompromised are at increased risk of pneumonia, but the national burden of pneumoniaassociated hospitalizations among the immunocompromised has not been fully characterized. [13] [14] [15] [16] [17] [18] Finally, disparities have been noted in pneumonia death rates by race/ethnicity. 19 To characterize the national burden of pneumonia after the introduction of PCV7, we analyzed hospital discharge data for pneumonia during 2001-2014.
Materials and Methods

Data Source
We used the National (Nationwide) Inpatient Sample (NIS) to retrospectively analyze hospital discharge data with a diagnosis of pneumonia for the general US population during [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] . 20 The NIS is a nationally representative database of hospitalizations and is the largest all-payer inpatient database in the United States. The full NIS includes > 7 million unweighted hospitalizations per year. For each discharge record in the NIS, we pulled up to 15 diagnoses (principal diagnosis plus 14 secondary diagnoses) that were coded on the basis of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).
Study Approval
Use of the NIS specifically prohibits identification of individual patients. This investigation was determined by the Centers for Disease Control and Prevention and the New York City Department of Health and Mental Hygiene to be nonhuman subject research.
Definitions
We defined a pneumonia-associated hospitalization as a hospitalization with a principal diagnosis of pneumonia (ICD-9-CM code 480-486, 487.0, 488.01, 488.11, or 488.81), or a secondary diagnosis of pneumonia if the principal diagnosis was respiratory failure (ICD-9-CM code 518.81, 518.82, 518.84, or 799.1) or sepsis (ICD-9-CM code 038, 785.52, 995.91, or 995.92). 7 Of note, ICD-9-CM codes 487.0, 488.01, 488.11, and 488.81 relate to "influenza with pneumonia"; we did not include other "influenza" ICD-9-CM codes within the 487 and 488 categories because they did not specify an associated "pneumonia." Together, these four ICD-9-CM codes accounted for 1.1% (SE, 0.01) of all pneumonia-associated hospitalizations during the study period.
A pneumonia episode was considered to be of unspecified etiology if the discharge record contained a principal diagnosis of "bronchopneumonia, organism unspecified" or "pneumonia, organism unspecified" (ICD-9-CM codes 485 and 486, respectively); all other pneumonia-associated hospitalizations that listed a pneumonia diagnostic code as the principal diagnosis other than ICD-9-CM codes 485 or 486 were considered to have a specified etiology.
Pneumonia-associated hospitalizations of persons who were immunocompromised were identified if an ICD-9-CM code for an immunocompromising condition was colisted on the discharge record 21 (e- Table 1 ).
Data Analysis
Estimates and standard errors of the number of pneumonia-associated hospitalizations were calculated from the NIS, using the Healthcare Cost and Utilization Project weighting methodology. 20, 22, 23 The unit of analysis was a hospitalization; NIS data do not have person identifiers, and therefore any repeat pneumonia-associated hospitalizations of the same patient were included.
Average annual and annual hospitalization rates with 95% CIs were expressed as the weighted number of hospitalizations per 100,000 persons of the corresponding population. Age-adjusted rates with 95% CIs were calculated by the direct method, with the 2000 projected US population as the standard; crude weights were calculated for specific age groups and income quartiles. Denominators were taken from the National Center for Health Statistics annual bridged race population estimates for the study period. 24 We used Poisson regression to calculate rate ratios and 95% CIs, and test for trends over time. A P value < .05 was considered statistically significant. Pneumonia-associated hospitalization records were examined by sex, age, race/ethnicity, region, ZIP code income quartile, month of admission, in-hospital death, colisting of immunocompromising conditions, and charges (in 2014 US dollars). Hospital charges reflected the amount that the medical facility billed for the hospitalization, but did not include professional (physician) fees. (Fig 1) .
The majority of pneumonia-associated hospitalizations listed a pneumonia principal diagnosis (76.8% [SE, 0.1] of pneumonia-associated hospitalizations), corresponding to an average annual age-adjusted hospitalization rate of 358.3 per 100,000 population (95% CI, 356.4-360.1) ( Table 2 ). The remaining pneumonia-associated hospitalizations listed a respiratory failure or sepsis principal diagnosis, corresponding to an average annual age-adjusted hospitalization rate of 106.6 per 100,000 population (95% CI, 105.8-107.3). The rate of pneumoniaassociated hospitalizations with a pneumonia principal diagnosis decreased over the study period (P < .0001) while the rate for those with a respiratory failure or sepsis principal diagnosis increased (P < .0001) (Fig 1) .
The majority of pneumonia-associated hospitalizations with a pneumonia principal diagnosis were of unspecified pneumonia etiology ( Table 2 ). The most common specified etiology among pneumoniaassociated hospitalizations listing a pneumonia principal diagnosis was nonpneumococcal bacteria (ICD-9-CM code 482), accounting for 7.6% (SE, 0.1) of overall pneumonia-associated hospitalizations.
In-Hospital Death
In-hospital death occurred in 7.4% (SE, 0.03) of pneumonia-associated hospitalizations (Table 1) . From 2001-2003 to 2012-2014, there was no significant change in the proportion of pneumonia-associated hospitalizations with in-hospital death. In-hospital death occurred in 3.9% (SE, 0.02) of pneumonia-associated hospitalizations listing a pneumonia principal diagnosis, vs 19.0% (SE, 0.1) of pneumonia-associated hospitalizations listing a respiratory failure or sepsis principal diagnosis.
Hospitalizations by Sex, Age Group, Race/ Ethnicity, Region, and Income Quartile Male subjects had a higher average annual age-adjusted rate of pneumonia-associated hospitalization than female subjects (Table 1) . Average annual age-adjusted rates of hospitalization decreased for both male and female subjects from 2001-2003 to 2012-2014 (Table 3 ).
The average annual rate of pneumonia-associated hospitalization was highest in those aged < 1 year and those aged $ 65 years ( Table 1 ). The proportion of pneumonia-associated hospitalizations with in-hospital death was highest among people aged $ 65 years. The rate of pneumonia-associated hospitalizations decreased from 2001-2003 to 2012-2014 for all age groups except for the 20-to 44-year and 45-to 64-year age groups (Table 3) .
Non-Hispanic American Indian/Alaskan Natives and non-Hispanic blacks had the highest average annual ageadjusted rates of pneumonia-associated hospitalization of all race/ethnicities; non-Hispanic Asian/Pacific Islanders had the lowest average annual age-adjusted rate ( Table 1 ). The proportion of pneumonia-associated hospitalizations with in-hospital death was highest among non-Hispanic Asian/Pacific Islanders, whereas it was lowest among non-Hispanic American Indian/ Alaskan Natives and Hispanics. Both non-Hispanic Asian/Pacific Islanders and Hispanics saw a decrease in the average annual age-adjusted rate of pneumoniaassociated hospitalizations from 2001-2003 to 2012-2014; the average annual age-adjusted rate of pneumonia-associated hospitalization increased among non-Hispanic whites and non-Hispanic blacks ( Table 3 ).
The South had the highest rate of pneumonia-associated hospitalizations of all regions, though in-hospital death occurred more often in the Northeast (Table 1 (Table 3 ).
The average annual rate of pneumonia-associated hospitalization decreased as income quartile increased ( Table 1 ). The proportion of pneumonia-associated hospitalizations with in-hospital death increased with increasing income quartile. The mean age at in-hospital death was lowest in the lowest income quartile (73. Figs 1-3) . In-hospital death occurred in 10.9% (SE, 0.1) of pneumonia-associated hospitalizations colisting an immunocompromising condition compared with 6.3% (SE, 0.03) among those not colisting an immunocompromising condition (P < .0001).
Seasonality
Age-adjusted pneumonia-associated hospitalization rates were highest from December through March (Fig 3A) . We focused on a period after the introduction of PCV7, and observed that the average annual age-adjusted rate of pneumonia-associated hospitalizations and the proportion with in-hospital death decreased during the study period. This downward trend, largely driven by a downward trend in pneumonia principal diagnoses, may be related to several factors, including PCV7 introduction, changes in coding practices, and changes in health-care delivery, among others. While these trends are reassuring, the rate of pneumonia-associated hospitalizations that involved a principal diagnosis of respiratory failure or sepsis tripled from 2001-2003 to 2012-2014. This is consistent with previously reported data, and likely reflects a coding bias. 7 Consistent with previous studies, infants and adults aged $ 65 years experienced higher average annual rates of pneumonia-associated hospitalization than other age groups. 6, 12 Pneumococcal and influenza vaccination are a primary means of pneumonia prevention among these age groups, but the proportion of the population vaccinated for these conditions remains below target levels. 25, 26 Meanwhile, average annual rates of pneumonia-associated hospitalization decreased during the study period for all age groups except persons aged 20-44 and 45-64 years. The reasons for the rise in pneumonia-associated hospitalization rate among these particular age groups are unclear.
Also consistent with previous studies, male subjects experienced higher average annual age-adjusted pneumonia-associated hospitalization rates than female subjects. 27 Several lifestyle, behavioral, and socioeconomic factors may play a role in this difference. 28 Male subjects also had a higher percentage of pneumonia-associated hospitalizations with in-hospital death than female subjects. Previous research has shown that differences in mortality persist even after adjusting for behavior and comorbidities, and sexspecific immune responses might play a role. 29 Although inroads have been made in quantifying and elucidating the cause of racial and ethnic health disparities in pneumonia, our data show that differences persist. 30, 31 Consistent with previous reports, nonHispanic blacks had among the highest rates of pneumonia-associated hospitalization among all race/ ethnicity groups-perhaps due to a higher prevalence of underlying pneumonia risk factors such as smoking and certain chronic conditions. 31-34 Furthermore, we found that non-Hispanic American Indian/Alaskan Natives had a high rate of pneumonia-associated hospitalizations compared with other race/ethnicities. These data are consistent with other studies that have examined health disparities among non-Hispanic American Indian/Alaskan Natives. 35, 36 Though non-Hispanic whites did not have as high a rate of pneumonia-associated hospitalizations compared with other race/ethnicities, the apparent increase in ageadjusted hospitalization rates over time among this demographic and among non-Hispanic blacks is concerning. Differences by race/ethnicity in the proportion of pneumonia-associated hospitalizations chestjournal.org with in-hospital death (eg, 6.2% in Hispanics vs 9.6% in non-Hispanic Asian/Pacific Islanders) were also identified.
The association between income quartile and pneumonia-associated hospitalization rates that we found is consistent with data from other investigations. 33 Lower income is associated with multiple pneumonia risk factors such as smoking, worse access to health care, and lower pneumococcal and influenza vaccination rates. 25, 34, 37 There are likely additional effects of race/ethnicity and income; however, without population denominators of the distribution of race/ethnicity within each of the US income quartiles, we were unable to create rates to describe this relationship. Paradoxically, the proportion of pneumonia-associated hospitalizations with in-hospital death increased with income quartile. We suspect that this might be an artifact of age, given that mean age at in-hospital death also increased with income quartile.
The proportion of pneumonia-associated hospitalizations listing an ICD-9-CM code for an immunocompromising condition almost doubled from 2001 to 2014. Part of our findings may be explained by persons with immunocompromising conditions living longer. 38, 39 While the data we present highlight the importance of monitoring pneumonia among immunocompromised individuals, caution should be taken in their interpretation for multiple reasons. First, it is possible that our data related to immune status are subject to some unrecognized bias, as the codes we used have not been validated through chart review. Furthermore, the median number of secondary diagnoses listed on the discharge record for any hospitalization (not just pneumonia-associated hospitalizations) almost doubled from 3.8 (SE, 0.03) during 2001-2003 to 7.5 (SE, 0.02) during 2012-2014 (P < .05). Thus, there is likely a bias over time to list secondary diagnoses on the discharge record, and this might explain why the proportion of pneumoniaassociated hospitalizations colisting an immunocompromising condition increased during the study period. Second, some of the ICD-9-CM codes we used to identify immunocompromising conditions include a wide spectrum of severity in which the early stages of disease might not greatly impair the immune system, thus potentially overestimating the proportion of pneumonia-associated hospitalizations involving immunocompromised people. Third, chronic kidney disease, a condition that can suppress the immune system, was purposely excluded from our analysis because additional subdiagnoses were added to the ICD-9-CM code for this condition in 2005. 40 When we tested the impact of including this ICD-9-CM code in our analysis, we observed a dramatic inflation in the proportion of pneumonia-associated hospitalizations colisting an immunocompromising condition starting in 2005 (e -Fig 4) . Fourth, our data do not capture outpatient treatment of pneumonia, and pneumonia in an immunocompetent person is more likely to be treated in the outpatient setting. 41 Understanding the etiology of pneumonia can help with targeting specific therapies for individual patients and with focusing public health interventions, but we found that > 60% of pneumonia-associated hospitalizations with a pneumonia principal diagnosis had no specified etiology. This is consistent with data from previous studies showing that a pneumonia etiology is often not identified even after extensive investigation. 2, 3 While hospital discharge data are useful for estimating trends in pneumonia-associated hospitalizations, there are limitations. The data presented reflect hospitalizations, not patients, and a single patient may be hospitalized more than once. As a sizeable proportion of patients with pneumonia are treated in the outpatient setting, our study estimates the more severe cases. We may have incorrectly estimated disease burden, due to use of nonspecific ICD-9-CM codes that included nonpneumonia illnesses and because we do not know the accuracy of the diagnoses listed on the discharge record. As administrative data can be affected by external factors such as reimbursement policies, the selection and distribution of principal and secondary diagnostic codes could be biased. 42 However, to overcome a well-documented selection bias in coding for pneumonia, we chose to define "pneumonia-associated hospitalizations" as discharge records in which there was either a pneumonia principal diagnosis or a pneumonia secondary diagnosis in combination with a principal diagnosis of respiratory failure or sepsis. 7 In conclusion, pneumonia causes significant morbidity and mortality in the United States. Populations such as the very young and older persons have historically faced the greatest risk, which is still the case today. Persons who are immunocompromised have emerged as a group representing an increasing proportion of pneumoniaassociated hospitalizations. Understanding the burden of pneumonia-associated hospitalizations can potentially inform clinical treatment and public health interventions, and should continue to be monitored. 
